Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Xylooligosaccharides (XOS) are short-chain sugar oligomers derived from the hydrolysis of xylan-rich plant materials. They are classified as prebiotics, which means they selectively stimulate the growth and/or activity of beneficial bacteria in the gut, particularly in the small intestine and colon. Several scientific studies have examined the effects of XOS on the composition of intestinal microbiota, showing that XOS supplementation can increase populations of Bifidobacteria and Lactobacilli. This can enhance gut barrier function and modulate immune responses, both of which support overall small intestine health.

In human and animal trials, XOS have demonstrated the ability to improve gut microbiota balance, increase production of short-chain fatty acids, and reduce markers of gut inflammation. Clinical studies are still relatively limited, but early evidence suggests beneficial effects on digestive function, stool frequency, and even some potential in reducing gastrointestinal infections. However, these findings are not as robust or numerous as those for more widely studied prebiotics like inulin or fructooligosaccharides (FOS).

In summary, the use of xylooligosaccharides to support the small intestine is based on scientific evidence, though the current body of research is moderate in size and strength. The evidence is promising, but more high-quality human clinical trials are needed to provide stronger validation.

More about xylooligosaccharides
More about Small Intestines

Other ingredients that support Small Intestines

Other body systems supported by xylooligosaccharides

Products containing xylooligosaccharides